{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464214576
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = u
| target = [[vimentin]]
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 499212-74-7
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| C=6440 | H=9968 | N=1708 | O=2016 | S=42
| molecular_weight = 150 kg/mol
}}

'''Pritumumab''' is a [[human]] [[monoclonal antibody]]<ref>[http://whqlibdoc.who.int/druginfo/INN_2004_list51.pdf WHO Drug Information]</ref> used in the treatment of [[brain cancer]].<ref>[http://www.nascentbiologics.com/news/science/70-proven-cancer-cure-back-in-the-hands-of-us-inventor-after-27-years-in-japan Nascent Biologics Proven Cancer Cure Back in the Hands Of U.S. Inventor After 27 Years In Japan]</ref>

==References==
{{reflist}}

{{Monoclonals for tumors}}

[[Category:Monoclonal antibodies for tumors]]
[[Category:Experimental cancer drugs]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}